The podcast focused on the issues that affect global health.
Every episode features leading voices from healthcare, government, and research sharing the latest thinking about the health issues that affect all of us. Listen in and expand your perspectives.
Towards the end of last year, our co-host Ken Berta (aka Surge) contracted COVID-19. Determined to add to our pool of knowledge on the virus and provide a resource for others, he kept a diary of his experience. In this episode, he talks candidly to fellow host, Dr. Rob Breiman (aka Spike) about his battle with COVID-19.
Having received several queries and questions from our listeners, in this episode Dr. Rob Breiman and Ken Berta, aka Spike and Surge, set out to provide some answers. They discuss trust in vaccines, COVID virus mutation, safely reopening schools and businesses, and the mitigations we’ll need to keep as the vaccine rolls out.
“I think healthcare is a right; everyone should have options”
In this episode of GHC3 Talks, Kathy McNamara, Associate Vice President of Clinical Affairs for the National Association of Community Health Centers joins our hosts Dr. Rob Breiman (Spike) and Ken Berta (Surge) on the podcast.
They talk about how the community health centers have responded to the challenges posed by COVID-19 and the burnout faced by dedicated staff who have been on the frontline since March.
In discussing the preparations needed to distribute a vaccine, Kathy highlights the importance of moving from macro to micro planning at the community level and the critical need for tailored messaging to be delivered by trusted members of the community.
“Investing in communications research is important. We need to understand who is hesitant, why they’re hesitant, whom do they trust as messengers, and what is it they really want to hear that would convince them it’s worth taking the vaccine.”
While the world watches and waits for a COVID vaccine to be reviewed and approved, Dr. Rob Breiman and Ken Berta, otherwise known as Spike and Surge, sit down with Dr. Walt Orenstein, Associate Director of the Emory Vaccine Center and Professor of Medicine, Pediatrics, Public Health and Epidemiology at Emory University and former Director of the U.S. National Immunization Program. They talk about what we should be looking for in the vaccine trial data and, perhaps more importantly, how we can persuade people to trust it.
03:00 — The focus for the first round of vaccination. Where will you be in line?
09:48 — A vaccine that stays in the vial is 0% effective.
10:40 — Papers not press releases – what should we be looking for in the vaccine trial data?
14:16 — Communication is key to combatting vaccine hesitancy.
16:49 — A one-size-fits-all approach to messaging simply won’t work.
18:30 — The COVID-19 vaccine shows the incredible technological advance in vaccine development. We aren’t cutting corners, we’re just getting better at what we do.
23:05 — What are the challenges in trying to immunize the whole world, and how can we combat them?
31:12 — Global vaccination will benefit poorer countries, and richer ones too.
In this episode of GHC3 Talks, Dr. Rob Breiman and Ken Berta are joined by Dr. Dan Salmon of John Hopkins University School of Public Health. In the wake of recent vaccine press releases, they discuss how to build trust in the COVID-19 vaccines, why that is important, and the crucial role that messaging will play.
“It’s much easier to help form views through information and knowledge and science than it is to change them once they’re existing. So we need to be a part of teaching people, educating people and creating the mindset.”
In this, the inaugural episode of the GHC3 podcast, our hosts Ken Berta and Dr. Rob Breiman discuss the complex and multifaceted issues surrounding COVID-19 vaccination. To help tackle this topic, they are joined by two special guests: Jim Lavery, Professor of Global Health Ethics at Emory University and Dr. Theresa Cullen, Director of Pima County Public Health Department.
Jim shines a light on the role ethics could, and should, play in the prioritization of vaccine allocation, while Dr. Theresa Cullen underlines the need for community collaboration and data-driven decisions.